April 11, 2017
Bristol-Myers Squibb Co. and Pfizer Inc. hit Zydus Pharmaceuticals Inc. with a patent infringement suit in Delaware federal court Monday, seeking to stop Zydus from receiving U.S. Food and Drug Administration approval for a generic version of their patented blood-thinning drug Eliquis.